Trademarkia Logo

Canada

C$
TQXIA
REGISTERED

on 17 Aug 2022

Last Applicant/ Owned by

CKD BIO CORPORATION

8, Chungjeong-ro, Seodaemun-guSeoul

KR

Serial Number

2046935 filed on 9th Jul 2020

Registration Number

TMA1138762 registered on 17th Aug 2022

Registration expiry Date

9th Jul 2030

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

1800 - 510 West Georgia StreetVancouver

BRITISH COLUMBIA

CA

V6B0M3

TQXIA

Trademark usage description

pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infection Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; Pharmaceutical preparations containing botulinum toxin for medical use for use in aesthetic procedures, namely, the treatment of wrinkles; Pharmaceutical preparations for treating and preventing skin diseases; Pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne, Pharmaceutical preparations for the treatment of blackheads, Pharmaceutical preparations for hydrating the skin during pregnancy; Medicated lotions, namely, acne medications, Medicated after-shave lotions, Medicated lotions, namely, medicated body moisturizers, Medicated diaper rash lotions, Medicated lotions for sunburn; Pharmaceutical agents for treating physically caused lesions, Pharmaceutical agents for epidermis, namely, topical anti-inflammatories; Injectable dermal fillers; Medicated acne pre-moistened wipes, Antibacterial wipes for medical and veterinary purposes; Pharmaceutical preparations for treating leg cramps, Pharmaceutical preparations, namely, menstrual symptom treatment preparations; Pharmaceutical preparations for the treatment of movement disorders, namely, myodystonia; Muscle relaxants; Preparations for the treatment of hyperhidrosis; Headache treatment preparations; Pain treatment preparations; Hemorrhoid preparations; Pharmaceutical preparations for the treatment of psychiatric disorders, namely, mood disorders, cognitive disorders, schizophrenia and bipolar disorders; Pharmaceutical preparations for the treatment of anxiety disorders; Pharmaceutical agents affecting sensory organs, namely, nose drops for medical purposes; Ophthalmic preparations; Antibiotics for dental use; Pharmaceutical preparations for use in dermatology, namely, hydrocortisone skin creams and antimicrobials for dermatological use; Pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders, Pharmaceutical preparations for orthopaedic purposes, namely, muscle relaxants; Pharmaceutical preparations for the treatment of digestive diseases; Pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction; Pharmaceutical preparations for treating physically caused lesions; Pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, Pharmaceutical preparations for the treatment of brain diseases and disorders, namely, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis, Pharmaceutical preparations for the treatment of diseases and disorders caused by chemical exposure, namely, pharmaceutical preparations for the treatment of respiratory diseases and disorders, for ophthalmological use and for the prevention and treatment of cancer; Cultures of microorganisms for medical use for the treatment of gastrointestinal disorders, immune health, iron absorption disorders and bone health, Cultures of microorganisms for medical use, namely, probiotic cultures for dietetic and nutritional supplement purposes, Cultures of microorganisms for use as an ingredient in the manufacture of dietary supplements, food supplements, vitamin and mineral preparations.


Classification kind code

11

Mark Details


Serial Number

2046935

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 4th Mar 2022
Agent Changed
Submitted for opposition 22
on 10th Dec 2021
Search Recorded
Submitted for opposition 20
on 10th Dec 2021
Examiner's First Report
Submitted for opposition 223
on 10th Dec 2021
Total Provisional Refusal
Submitted for opposition 256
on 21st Jun 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 20th Aug 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 20th Aug 2020
Formalized
Submitted for opposition 1
on 20th Aug 2020
Created
Submitted for opposition 228
on 9th Jul 2020
International Registration
Submitted for opposition 30
on 9th Jul 2020
Filed